Study Title and Description
Treatment of chronic hepatitis B with interferon alfa-2b.
Key Questions Addressed
|4||Key Question 4. How effective is antiviral treatment in improving intermediate outcomes among nonpregnant adolescents and adults with chronic HBV infection, including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated by loss of HBeAg or acquisition of the antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated by loss of HBsAg or acquisition of hepatitis B surface antibody [anti-HBs])?|
|5||Key Question 5. How effective is antiviral treatment in improving health outcomes among nonpregnant adolescents and adults with chronic HBV infection?|
|6||Key Question 6. What are the harms associated with antiviral treatment in nonpregnant adolescents and adults with chronic HBV infection?|
Primary Publication Information
|Title||Treatment of chronic hepatitis B with interferon alfa-2b.|
|Author||Müller R., Baumgarten R., Markus R., Schulz M., Wittenberg H., Hintsche-Kilger B., Fengler JD., Von Wussow P., Meisel H., Klein H.|
|Country||Abteilung für Gastroenterologie und Hepatologie, Zentrum für Innere Medizin und Dermatologie, Medizinische Hochschule Hannover, Federal Republic of Germany.|
Pubmed ID: 2079572
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Key Questions 1-7
Results & Comparisons
No Results found.